Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults
- PMID: 34023936
- PMCID: PMC8140562
- DOI: 10.1007/s00431-021-04124-w
Serum IgG levels in children 6 months after SARS-CoV-2 infection and comparison with adults
Abstract
Since the outbreak of SARS-CoV-2 among the population has occurred quite recently, there is a lack of evidence on the long-term duration of antibody response, especially in children. It is therefore crucial to clarify this aspect, considering its implications in the development of successful surveillance strategies, therapies, and vaccinations. The aim of this study was to assess the antibody response in a children group after SARS-CoV-2 infection, and to compare it with that of their parents affected by SARS-CoV-2 infection. We enrolled 12 children and their parents, both groups being affected by COVID-19 in April 2020. In the children's group, we collected real-time RT-PCR cycle threshold (Ct) values and gene characterization of first nasal-throat swab at the time of diagnosis (T0); 30 days after the diagnosis (T30), we performed blood tests to detect anti-SARS-CoV-2 IgM and IgG. Finally, 180 days after the diagnosis (T180), we measured anti-SARS-CoV-2 IgG in both children and parents. In children, antibody levels declined significantly at 180 days (T180) after first measurement (T30). There were no significant differences in IgG level related to age, sex, and clinical manifestations. We found a significant correlation between IgG titers at T30 and Ct value of gene N. Children showed a lower level of antibodies against SARS-CoV-2 at T180 compared to their parents.Conclusion: Antibody responses in children waned 180 days after SARS-CoV-2 infection, and at the same time, their parents showed a different antibody response to the virus. These results highlight that serological tests should be used with caution in surveillance strategies among the general population. What is known: • Currently is not known how long antibody response will be maintained or if it protects from reinfection. • Recent reports in adults suggest that antibodies to SARS-CoV-2 declined several months after infection, but data are missing in pediatric age. What is new: • We showed that antibody responses to SARS-CoV-2 wane several months after infection also in children with quantitative differences in antibody levels between children and adults. • In this context, serological tests should be used with caution in surveillance strategies.
Keywords: Antibody response; COVID-19; Children; Immunity.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978. doi: 10.1002/uog.23639. Ultrasound Obstet Gynecol. 2021. PMID: 33798280 Free PMC article.
-
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22. Microbiol Spectr. 2021. PMID: 34550000 Free PMC article.
-
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).Pediatrics. 2020 Dec;146(6):e2020018242. doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2. Pediatrics. 2020. PMID: 32879033
-
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.Ann Intern Med. 2021 Jun;174(6):811-821. doi: 10.7326/M20-7547. Epub 2021 Mar 16. Ann Intern Med. 2021. PMID: 33721517 Free PMC article. Review.
-
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection-Final Update of a Living, Rapid Review.Ann Intern Med. 2023 Jan;176(1):85-91. doi: 10.7326/M22-1745. Epub 2022 Nov 29. Ann Intern Med. 2023. PMID: 36442059 Free PMC article. Review.
Cited by
-
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection.JAMA Netw Open. 2022 Jul 1;5(7):e2221616. doi: 10.1001/jamanetworkopen.2022.21616. JAMA Netw Open. 2022. PMID: 35816313 Free PMC article.
-
Clinical picture and long-term symptoms of SARS-CoV-2 infection in an Italian pediatric population.Ital J Pediatr. 2022 May 21;48(1):79. doi: 10.1186/s13052-022-01270-1. Ital J Pediatr. 2022. PMID: 35598023 Free PMC article.
-
Three-year Seroprevalence of SARS-CoV-2 Nucleocapsid Protein Antibody Among Children, Parental Awareness, and Contributors of Infection: A Single-school Cohort Study in Chiba, Japan.J Epidemiol. 2025 Jun 5;35(6):278-286. doi: 10.2188/jea.JE20240284. Epub 2025 Feb 28. J Epidemiol. 2025. PMID: 39710421 Free PMC article.
-
Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention.Vaccines (Basel). 2021 Sep 8;9(9):1002. doi: 10.3390/vaccines9091002. Vaccines (Basel). 2021. PMID: 34579240 Free PMC article. Review.
-
Emergency Department Admissions of Children with Chest Pain before and during COVID-19 Pandemic.Children (Basel). 2023 Jan 30;10(2):246. doi: 10.3390/children10020246. Children (Basel). 2023. PMID: 36832377 Free PMC article.
References
-
- World Health Organization Press Conference. The World Health Organization (WHO) has officially named the disease caused by the novel coronavirus as COVID-19. Available online: https://www.who.int/ emergencies/diseases/novel-coronavirus-2019.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous